Rare diseases
Investigational molecules
Locations
Agiou Thoma (goudi) 17, 115 27 Athens, Greece
Laiko General Hospital Of Athens in Athens, Greece specialises in clinical trials of conditions such as Non-small cell lung cancer, Colitis ulcerative, Type 2 diabetes mellitus, Crohn's disease, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in Type 2 Diabetes and related metabolic disorders, focusing on innovative treatments that address both obesity and cardiovascular risk. The center's work in this area aims to improve patient outcomes through novel therapeutic approaches.
By integrating cutting-edge research with clinical practice, the center is enhancing the management of chronic conditions associated with metabolic health.
Specializing in Hemophilia and other blood disorders, the center is pioneering treatments that significantly reduce bleeding episodes and improve quality of life for patients. The focus is on both prophylactic and gene therapy approaches.
Through advanced research, the center is setting new standards in the treatment of hereditary blood disorders.
The center is advancing the field of oncology with a focus on innovative therapies for melanoma and lymphoma. By exploring combination therapies and novel agents, the center aims to improve survival rates and reduce recurrence.
Research efforts are directed towards developing personalized treatment plans that enhance patient outcomes.
With a strong emphasis on rheumatoid arthritis and systemic lupus erythematosus, the center is exploring new therapeutic options that target the underlying mechanisms of these diseases. The goal is to provide more effective and safer treatment alternatives.
Innovative research is leading to breakthroughs in understanding and managing autoimmune conditions.
The center is a leader in the study of IgA Nephropathy and other kidney diseases, focusing on reducing proteinuria and improving renal function. Research in this area is crucial for developing therapies that slow disease progression.
By advancing nephrology research, the center is contributing to better management strategies for kidney-related conditions.
Focusing on COVID-19 and other respiratory infections, the center is involved in trials that evaluate the efficacy of immune modulation strategies. This research is vital for improving treatment protocols for hospitalized patients.
The center's work is instrumental in shaping public health responses to infectious disease outbreaks.
Clinical trials currently enrolling participants at this site.
Efficacy and Safety of Once‑Daily Oral ASC30 in Adults with Obesity or Overweight: A Phase III Randomized Placebo‑Controlled Trial
GreeceA Phase III Study of ASC30 Sodium for Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes
GreeceEffect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
GreeceGreeceRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
GreeceStudy of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
GreeceStudy of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
GreecePhase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis
GreeceLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
GreeceA Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer
GreecePhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
GreeceStudy of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)
GreeceMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
